Billy Wynne

Today, the Food and Drug Administration (FDA) announced additional labeling changes for menopausal hormone therapy (MHT) products and outlined efforts to expand access to treatment.…

Today, the Department of Health and Human Services (HHS) Office for Civil Rights (OCR) published a final rule excluding gender dysphoria that does not result…